Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q7Z6Z7 (HUWE1_HUMAN)

Last modified November 3, 2009. Version 75. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (7) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    E3 ubiquitin-protein ligase HUWE1
    EC=6.3.2.-
Alternative name(s):
    HECT, UBA and WWE domain-containing protein 1
    Upstream regulatory element-binding protein 1
      Short name=URE-binding protein 1
      Short name=URE-B1
    Mcl-1 ubiquitin ligase E3
      Short name=Mule
    ARF-binding protein 1
      Short name=ARF-BP1
    Large structure of UREB1
      Short name=LASU1
    Homologous to E6AP carboxyl terminus homologous protein 9
      Short name=HectH9
Gene names
Name: HUWE1
Synonyms: KIAA0312, KIAA1578, UREB1
ORF Names: HSPC272
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length4374 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins. Regulates apoptosis by catalyzing the polyubiquitination and degradation of MCL1. Also ubiquitinates the p53 tumor suppressor and core histones including H1, H2A, H2B, H3 and H4. Binds to an upstream initiator-like sequence in the preprodynorphin gene. Regulates neural differentiation and proliferation by catalyzing the polyubiquitination and degradation of MYCN. May regulate abundance of CDC6 after DNA damage by polyubiquitinating and targeting CDC6 to degradation. Ref.1 Ref.2 Ref.3 Ref.14 Ref.17 Ref.23

Pathway

Protein modification; protein ubiquitination.

Subunit structure

Interacts with isoform p14ARF of CDKN2A which strongly inhibits HUWE1 ubiquitin ligase activity. Interacts with MYCN and CDC6. Ref.1 Ref.17 Ref.23

Subcellular location

Cytoplasm. Nucleus. Note: Mainly expressed in the cytoplasm of most tissues, except in the nucleus of spermatogonia, primary spermatocytes and neuronal cells By similarity. Predominantly cytosolic or perinuclear in some colorectal carcinoma cells.

Tissue specificity

Weakly expressed in heart, brain and placenta but not in other tissues. Expressed in a number of cell lines, predominantly in those from colorectal carcinomas. Ref.14

Domain

The HECT domain mediates inhibition of the transcriptional activity of p53.

Post-translational modification

Phosphorylated on tyrosine; phosphorylation is probably required for its ability to inhibit TP53 transactivation By similarity.

Phosphorylated upon DNA damage, probably by ATM or ATR. Ref.13 Ref.15 Ref.16 Ref.18 Ref.19 Ref.20 Ref.21 Ref.22 Ref.24

Involvement in disease

Defects in HUWE1 are the cause of mental retardation syndromic X-linked Turner type (MRXST) [MIM:300706]; also known as mental retardation and macrocephaly syndrome. MRXST shows clinical variability. Associated phenotypes include macrocephaly and variable contractures.

A chromosomal microduplication involving HUWE1 and HSD17B10 is the cause of mental retardation X-linked type 17 (MRX17) [MIM:300705]; also known as mental retardation X-linked type 31 (MRX31). Mental retardation is characterized by significantly sub-average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. In contrast to syndromic or specific X-linked mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation. Ref.26

Sequence similarities

Belongs to the TOM1/PTR1 family.

Contains 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain.

Contains 1 UBA domain.

Contains 1 UIM (ubiquitin-interacting motif) repeat.

Contains 1 WWE domain.

Sequence caution

The sequence AAF28950.1 differs from that shown. Reason: Frameshift at position 4356.

The sequence BAB13404.1 differs from that shown. Reason: Miscellaneous discrepancy. Chimeric cDNA, contains the C-terminal part of ATP5I.

The sequence BAC06833.1 differs from that shown. Reason: Frameshift at positions 982 and 1055.

Binary interactions

With

Entry

#Exp.

IntAct

Notes

CDKN2AQ8N7262EBI-625934,EBI-625922
TP53P046372EBI-625934,EBI-366083

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q7Z6Z7-1)

Also known as: LASU1; Large structure of UREB1;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q7Z6Z7-2)

The sequence of this isoform differs from the canonical sequence as follows:
     3016-3031: Missing.
Note: No experimental confirmation available.
Isoform 3 (identifier: Q7Z6Z7-3)

The sequence of this isoform differs from the canonical sequence as follows:
     982-990: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 43744374E3 ubiquitin-protein ligase HUWE1
PRO_0000120340

Regions

Domain1316 – 135540UBA
Repeat1370 – 138920UIM
Domain1603 – 168078WWE
Domain4038 – 4374337HECT
Compositional bias2295 – 2469175Glu-rich
Compositional bias2427 – 249064Asp-rich
Compositional bias3483 – 355068Thr-rich

Sites

Active site43411Glycyl thioester intermediate

Amino acid modifications

Modified residue5091N6-acetyllysine Ref.25
Modified residue10841Phosphoserine Ref.21
Modified residue13681Phosphoserine Ref.24
Modified residue13951Phosphoserine Ref.13 Ref.16 Ref.24
Modified residue18401N6-acetyllysine Ref.25
Modified residue19071Phosphoserine Ref.13 Ref.15 Ref.16 Ref.19 Ref.20 Ref.22 Ref.24
Modified residue22481N6-acetyllysine Ref.25
Modified residue23621Phosphoserine Ref.13 Ref.15 Ref.16 Ref.22 Ref.24
Modified residue23651Phosphoserine Ref.24
Modified residue23771Phosphoserine Ref.18
Modified residue25261Phosphoserine Ref.21
Modified residue28871Phosphoserine Ref.16 Ref.24
Modified residue29181Phosphoserine Ref.16
Modified residue36621Phosphoserine Ref.24
Modified residue37571Phosphoserine By similarity
Modified residue37971Phosphoserine Ref.18
Modified residue38081Phosphoserine Ref.15
Modified residue38161Phosphoserine Ref.15 Ref.18
Modified residue38221Phosphothreonine Ref.18
Modified residue39191Phosphoserine Ref.15 Ref.24
Modified residue39241Phosphothreonine Ref.15 Ref.24
Modified residue39271Phosphothreonine Ref.15 Ref.24
Modified residue42711Phosphotyrosine By similarity

Natural variations

Alternative sequence982 – 9909Missing in isoform 3.
VSP_015272
Alternative sequence3016 – 303116Missing in isoform 2.
VSP_011146
Natural variant29811R → H in MRXS-Turner. Ref.26
VAR_045670
Natural variant40131R → W in MRXS-Turner. Ref.26
VAR_045671
Natural variant41871R → C in MRXS-Turner. Ref.26
VAR_045672

Experimental info

Mutagenesis42681Y → S: Loss of activity. Ref.14
Mutagenesis43411C → A or D: Loss of activity. Ref.1 Ref.2 Ref.14 Ref.23
Sequence conflict11111K → N Ref.5
Sequence conflict11241P → L Ref.1
Sequence conflict11241P → L Ref.5
Sequence conflict11901D → H Ref.5
Sequence conflict19621Missing Ref.6
Sequence conflict23101Q → H Ref.6
Sequence conflict2451 – 24533GEE → ARG Ref.8
Sequence conflict25251H → Y Ref.5
Sequence conflict25251H → Y Ref.8
Sequence conflict40221R → L in AAH02602. Ref.9

Secondary structure

.................................................................... 4374
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 (LASU1) (Large structure of UREB1) [UniParc].

Last modified August 30, 2005. Version 3.
Checksum: FA9D3A7712F6393B

FASTA4,374481,891
        10         20         30         40         50         60 
MKVDRTKLKK TPTEAPADCR ALIDKLKVCN DEQLLLELQQ IKTWNIGKCE LYHWVDLLDR 

        70         80         90        100        110        120 
FDGILADAGQ TVENMSWMLV CDRPEREQLK MLLLAVLNFT ALLIEYSFSR HLYSSIEHLT 

       130        140        150        160        170        180 
TLLASSDMQV VLAVLNLLYV FSKRSNYITR LGSDKRTPLL TRLQHLAESW GGKENGFGLA 

       190        200        210        220        230        240 
ECCRDLHMMK YPPSATTLHF EFYADPGAEV KIEKRTTSNT LHYIHIEQLD KISESPSEIM 

       250        260        270        280        290        300 
ESLTKMYSIP KDKQMLLFTH IRLAHGFSNH RKRLQAVQAR LHAISILVYS NALQESANSI 

       310        320        330        340        350        360 
LYNGLIEELV DVLQITDKQL MEIKAASLRT LTSIVHLERT PKLSSIIDCT GTASYHGFLP 

       370        380        390        400        410        420 
VLVRNCIQAM IDPSMDPYPH QFATALFSFL YHLASYDAGG EALVSCGMME ALLKVIKFLG 

       430        440        450        460        470        480 
DEQDQITFVT RAVRVVDLIT NLDMAAFQSH SGLSIFIYRL EHEVDLCRKE CPFVIKPKIQ 

       490        500        510        520        530        540 
RPNTTQEGEE METDMDGVQC IPQRAALLKS MLNFLKKAIQ DPAFSDGIRH VMDGSLPTSL 

       550        560        570        580        590        600 
KHIISNAEYY GPSLFLLATE VVTVFVFQEP SLLSSLQDNG LTDVMLHALL IKDVPATREV 

       610        620        630        640        650        660 
LGSLPNVFSA LCLNARGLQS FVQCQPFERL FKVLLSPDYL PAMRRRRSSD PLGDTASNLG 

       670        680        690        700        710        720 
SAVDELMRHQ PTLKTDATTA IIKLLEEICN LGRDPKYICQ KPSIQKADGT ATAPPPRSNH 

       730        740        750        760        770        780 
AAEEASSEDE EEEEVQAMQS FNSTQQNETE PNQQVVGTEE RIPIPLMDYI LNVMKFVESI 

       790        800        810        820        830        840 
LSNNTTDDHC QEFVNQKGLL PLVTILGLPN LPIDFPTSAA CQAVAGVCKS ILTLSHEPKV 

       850        860        870        880        890        900 
LQEGLLQLDS ILSSLEPLHR PIESPGGSVL LRELACAGNV ADATLSAQAT PLLHALTAAH 

       910        920        930        940        950        960 
AYIMMFVHTC RVGQSEIRSI SVNQWGSQLG LSVLSKLSQL YCSLVWESTV LLSLCTPNSL 

       970        980        990       1000       1010       1020 
PSGCEFGQAD MQKLVPKDEK AGTTQGGKRS DGEQDGAAGS MDASTQGLLE GIGLDGDTLA 

      1030       1040       1050       1060       1070       1080 
PMETDEPTAS DSKGKSKITP AMAARIKQIK PLLSASSRLG RALAELFGLL VKLCVGSPVR 

      1090       1100       1110       1120       1130       1140 
QRRSHHAAST TTAPTPAARS TASALTKLLT KGLSWQPPPY TPTPRFRLTF FICSVGFTSP 

      1150       1160       1170       1180       1190       1200 
MLFDERKYPY HLMLQKFLCS GGHNALFETF NWALSMGGKV PVSEGLEHSD LPDGTGEFLD 

      1210       1220       1230       1240       1250       1260 
AWLMLVEKMV NPTTVLESPH SLPAKLPGGV QNFPQFSALR FLVVTQKAAF TCIKNLWNRK 

      1270       1280       1290       1300       1310       1320 
PLKVYGGRMA ESMLAILCHI LRGEPVIRER LSKEKEGSRG EEDTGQEEGG SRREPQVNQQ 

      1330       1340       1350       1360       1370       1380 
QLQQLMDMGF TREHAMEALL NTSTMEQATE YLLTHPPPIM GGVVRDLSMS EEDQMMRAIA 

      1390       1400       1410       1420       1430       1440 
MSLGQDIPMD QRAESPEEVA CRKEEEERKA REKQEEEEAK CLEKFQDADP LEQDELHTFT 

      1450       1460       1470       1480       1490       1500 
DTMLPGCFHL LDELPDTVYR VCDLIMTAIK RNGADYRDMI LKQVVNQVWE AADVLIKAAL 

      1510       1520       1530       1540       1550       1560 
PLTTSDTKTV SEWISQMATL PQASNLATRI LLLTLLFEEL KLPCAWVVES SGILNVLIKL 

      1570       1580       1590       1600       1610       1620 
LEVVQPCLQA AKEQKEVQTP KWITPVLLLI DFYEKTAISS KRRAQMTKYL QSNSNNWRWF 

      1630       1640       1650       1660       1670       1680 
DDRSGRWCSY SASNNSTIDS AWKSGETSVR FTAGRRRYTV QFTTMVQVNE ETGNRRPVML 

      1690       1700       1710       1720       1730       1740 
TLLRVPRLNK NSKNSNGQEL EKTLEESKEM DIKRKENKGN DTPLALESTN TEKETSLEET 

      1750       1760       1770       1780       1790       1800 
KIGEILIQGL TEDMVTVLIR ACVSMLGVPV DPDTLHATLR LCLRLTRDHK YAMMFAELKS 

      1810       1820       1830       1840       1850       1860 
TRMILNLTQS SGFNGFTPLV TLLLRHIIED PCTLRHTMEK VVRSAATSGA GSTTSGVVSG 

      1870       1880       1890       1900       1910       1920 
SLGSREINYI LRVLGPAACR NPDIFTEVAN CCIRIALPAP RGSGTASDDE FENLRIKGPN 

      1930       1940       1950       1960       1970       1980 
AVQLVKTTPL KPSPLPVIPD TIKEVIYDML NALAAYHAPE EADKSDPKPG VMTQEVGQLL 

      1990       2000       2010       2020       2030       2040 
QDMGDDVYQQ YRSLTRQSSD FDTQSGFSIN SQVFAADGAS TETSASGTSQ GEASTPEESR 

      2050       2060       2070       2080       2090       2100 
DGKKDKEGDR ASEEGKQKGK GSKPLMPTST ILRLLAELVR SYVGIATLIA NYSYTVGQSE 

      2110       2120       2130       2140       2150       2160 
LIKEDCSVLA FVLDHLLPHT QNAEDKDTPA LARLFLASLA AAGSGTDAQV ALVNEVKAAL 

      2170       2180       2190       2200       2210       2220 
GRALAMAEST EKHARLQAVM CIISTIMESC PSTSSFYSSA TAKTQHNGMN NIIRLFLKKG 

      2230       2240       2250       2260       2270       2280 
LVNDLARVPH SLDLSSPNMA NTVNAALKPL ETLSRIVNQP SSLFGSKSAS SKNKSEQDAQ 

      2290       2300       2310       2320       2330       2340 
GASQDSSSNQ QDPGEPGEAE VQEEDHDVTQ TEVADGDIMD GEAETDSVVI AGQPEVLSSQ 

      2350       2360       2370       2380       2390       2400 
EMQVENELED LIDELLERDG GSGNSTIIVS RSGEDESQED VLMDEAPSNL SQASTLQANR 

      2410       2420       2430       2440       2450       2460 
EDSMNILDPE DEEEHTQEED SSGSNEDEDD SQDEEEEEEE DEEDDQEDDE GEEGDEDDDD 

      2470       2480       2490       2500       2510       2520 
DGSEMELDED YPDMNASPLV RFERFDREDD LIIEFDNMFS SATDIPPSPG NIPTTHPLMV 

      2530       2540       2550       2560       2570       2580 
RHADHSSLTL GSGSSTTRLT QGIGRSQRTL RQLTANTGHT IHVHYPGNRQ PNPPLILQRL 

      2590       2600       2610       2620       2630       2640 
LGPSAAADIL QLSSSLPLQS RGRARLLVGN DDVHIIARSD DELLDDFFHD QSTATSQAGT 

      2650       2660       2670       2680       2690       2700 
LSSIPTALTR WTEECKVLDA ESMHDCVSVV KVSIVNHLEF LRDEELEERR EKRRKQLAEE 

      2710       2720       2730       2740       2750       2760 
ETKITDKGKE DKENRDQSAQ CTASKSNDST EQNLSDGTPM PDSYPTTPSS TDAATSESKE 

      2770       2780       2790       2800       2810       2820 
TLGTLQSSQQ QPTLPTPPAL GEVPQELQSP AGEGGSSTQL LMPVEPEELG PTRPSGEAET 

      2830       2840       2850       2860       2870       2880 
TQMELSPAPT ITSLSPERAE DSDALTAVSS QLEGSPMDTS SLASCTLEEA VGDTSAAGSS 

      2890       2900       2910       2920       2930       2940 
EQPRAGSSTP GDAPPAVAEV QGRSDGSGES AQPPEDSSPP ASSESSSTRD SAVAISGADS 

      2950       2960       2970       2980       2990       3000 
RGILEEPLPS TSSEEEDPLA GISLPEGVDP SFLAALPDDI RREVLQNQLG IRPPTRTAPS 

      3010       3020       3030       3040       3050       3060 
TNSSAPAVVG NPGVTEVSPE FLAALPPAIQ EEVLAQQRAE QQRRELAQNA SSDTPMDPVT 

      3070       3080       3090       3100       3110       3120 
FIQTLPSDLR RSVLEDMEDS VLAVMPPDIA AEAQALRREQ EARQRQLMHE RLFGHSSTSA 

      3130       3140       3150       3160       3170       3180 
LSAILRSPAF TSRLSGNRGV QYTRLAVQRG GTFQMGGSSS HNRPSGSNVD TLLRLRGRLL 

      3190       3200       3210       3220       3230       3240 
LDHEALSCLL VLLFVDEPKL NTSRLHRVLR NLCYHAQTRH WVIRSLLSIL QRSSESELCI 

      3250       3260       3270       3280       3290       3300 
ETPKLTTSEE KGKKSSKSCG SSSHENRPLD LLHKMESKSS NQLSWLSVSM DAALGCRTNI 

      3310       3320       3330       3340       3350       3360 
FQIQRSGGRK HTEKHASGGS TVHIHPQAAP VVCRHVLDTL IQLAKVFPSH FTQQRTKETN 

      3370       3380       3390       3400       3410       3420 
CESDRERGNK ACSPCSSQSS SSGICTDFWD LLVKLDNMNV SRKGKNSVKS VPVSAGGEGE 

      3430       3440       3450       3460       3470       3480 
TSPYSLEASP LGQLMNMLSH PVIRRSSLLT EKLLRLLSLI SIALPENKVS EAQANSGSGA 

      3490       3500       3510       3520       3530       3540 
SSTTTATSTT STTTTTAAST TPTPPTAPTP VTSAPALVAA TAISTIVVAA STTVTTPTTA 

      3550       3560       3570       3580       3590       3600 
TTTVSISPTT KGSKSPAKVS DGGSSSTDFK MVSSGLTENQ LQLSVEVLTS HSCSEEGLED 

      3610       3620       3630       3640       3650       3660 
AANVLLQLSR GDSGTRDTVL KLLLNGARHL GYTLCKQIGT LLAELREYNL EQQRRAQCET 

      3670       3680       3690       3700       3710       3720 
LSPDGLPEEQ PQTTKLKGKM QSRFDMAENV VIVASQKRPL GGRELQLPSM SMLTSKTSTQ 

      3730       3740       3750       3760       3770       3780 
KFFLRVLQVI IQLRDDTRRA NKKAKQTGRL GSSGLGSASS IQAAVRQLEA EADAIIQMVR 

      3790       3800       3810       3820       3830       3840 
EGQRARRQQQ AATSESSQSE ASVRREESPM DVDQPSPSAQ DTQSIASDGT PQGEKEKEER 

      3850       3860       3870       3880       3890       3900 
PPELPLLSEQ LSLDELWDML GECLKELEES HDQHAVLVLQ PAVEAFFLVH ATERESKPPV 

      3910       3920       3930       3940       3950       3960 
RDTRESQLAH IKDEPPPLSP APLTPATPSS LDPFFSREPS SMHISSSLPP DTQKFLRFAE 

      3970       3980       3990       4000       4010       4020 
THRTVLNQIL RQSTTHLADG PFAVLVDYIR VLDFDVKRKY FRQELERLDE GLRKEDMAVH 

      4030       4040       4050       4060       4070       4080 
VRRDHVFEDS YRELHRKSPE EMKNRLYIVF EGEEGQDAGG LLREWYMIIS REMFNPMYAL 

      4090       4100       4110       4120       4130       4140 
FRTSPGDRVT YTINPSSHCN PNHLSYFKFV GRIVAKAVYD NRLLECYFTR SFYKHILGKS 

      4150       4160       4170       4180       4190       4200 
VRYTDMESED YHFYQGLVYL LENDVSTLGY DLTFSTEVQE FGVCEVRDLK PNGANILVTE 

      4210       4220       4230       4240       4250       4260 
ENKKEYVHLV CQMRMTGAIR KQLAAFLEGF YEIIPKRLIS IFTEQELELL ISGLPTIDID 

      4270       4280       4290       4300       4310       4320 
DLKSNTEYHK YQSNSIQIQW FWRALRSFDQ ADRAKFLQFV TGTSKVPLQG FAALEGMNGI 

      4330       4340       4350       4360       4370 
QKFQIHRDDR STDRLPSAHT CFNQLDLPAY ESFEKLRHML LLAIQECSEG FGLA 

« Hide

Isoform 2.

Checksum: D30775B19F710F6F
Show »

FASTA4,358480,198
Isoform 3.

Checksum: E8A8FFC3C7EB9B24
Show »

FASTA4,365481,018

References

« Hide 'large scale' references
[1]"ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor."
Chen D., Kon N., Li M., Zhang W., Qin J., Gu W.
Cell 121:1071-1083(2005) [PubMed: 15989956] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH CDKN2A, MUTAGENESIS OF CYS-4341.
[2]"Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis."
Zhong Q., Gao W., Du F., Wang X.
Cell 121:1085-1095(2005) [PubMed: 15989957] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, MUTAGENESIS OF CYS-4341.
[3]"Characterization of E3Histone, a novel testis ubiquitin protein ligase which ubiquitinates histones."
Liu Z., Oughtred R., Wing S.S.
Mol. Cell. Biol. 25:2819-2831(2005) [PubMed: 15767685] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION.
[4]"The DNA sequence of the human X chromosome."
Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C. expand/collapse author list , Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A., Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S., Rogers J., Bentley D.R.
Nature 434:325-337(2005) [PubMed: 15772651] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[5]"Homo sapiens LASU1 (large structure of UREB1) mRNA, complete cds."
Miyazaki K., Okamoto Y., Sakamoto M., Kato C., Ozaki T., Watanabe K., Nakagawara A.
Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 959-4374 (ISOFORM 3).
Tissue: Brain.
[6]"Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro."
Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.
DNA Res. 4:141-150(1997) [PubMed: 9205841] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1166-4374 (ISOFORM 2).
Tissue: Brain.
[7]"Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro."
Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.
DNA Res. 7:273-281(2000) [PubMed: 10997877] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1246-2418.
Tissue: Brain.
[8]"Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells."
Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G., Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W., Tao J., Huang Q.-H., Zhou J., Hu G.-X. expand/collapse author list , Gu J., Chen S.-J., Chen Z.
Genome Res. 10:1546-1560(2000) [PubMed: 11042152] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2451-4374.
Tissue: Umbilical cord blood.
[9]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3953-4374.
Tissue: Ovary and Placenta.
[10]Kim J.W., Lee Y., Hong Y.M., Hong M., Choe I.S.
Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 4029-4374.
[11]"Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)."
Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4067-4374.
[12]"The full-ORF clone resource of the German cDNA consortium."
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I.
BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4320-4374.
Tissue: Melanoma.
[13]"Large-scale characterization of HeLa cell nuclear phosphoproteins."
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1395; SER-1907 AND SER-2362, MASS SPECTROMETRY.
Tissue: Epithelium.
[14]"Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein."
Yoon S.Y., Lee Y., Kim J.H., Chung A.-S., Joo J.H., Kim C.-N., Kim N.-S., Choe I.S., Kim J.W.
Biochem. Biophys. Res. Commun. 326:7-17(2005) [PubMed: 15567145] [Abstract]
Cited for: FUNCTION, TISSUE SPECIFICITY, MUTAGENESIS OF TYR-4268 AND CYS-4341.
[15]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1907; SER-2362; SER-3808; SER-3816; SER-3919; THR-3924 AND THR-3927, MASS SPECTROMETRY.
Tissue: Epithelium.
[16]"A probability-based approach for high-throughput protein phosphorylation analysis and site localization."
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.
Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1395; SER-1907; SER-2362; SER-2887 AND SER-2918, MASS SPECTROMETRY.
Tissue: Epithelium.
[17]"Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage."
Hall J.R., Kow E., Nevis K.R., Lu C.K., Luce K.S., Zhong Q., Cook J.G.
Mol. Biol. Cell 18:3340-3350(2007) [PubMed: 17567951] [Abstract]
Cited for: FUNCTION, INTERACTION WITH CDC6.
[18]"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage."
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.
Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2377; SER-3797; SER-3816 AND THR-3822, MASS SPECTROMETRY.
[19]"Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis."
Wang B., Malik R., Nigg E.A., Korner R.
Anal. Chem. 80:9526-9533(2008) [PubMed: 19007248] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1907, MASS SPECTROMETRY.
[20]"Phosphoproteome of resting human platelets."
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A.
J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1907, MASS SPECTROMETRY.
Tissue: Platelet.
[21]"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084 AND SER-2526, MASS SPECTROMETRY.
[22]"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1907 AND SER-2362, MASS SPECTROMETRY.
[23]"The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein."
Zhao X., Heng J.I.-T., Guardavaccaro D., Jiang R., Pagano M., Guillemot F., Iavarone A., Lasorella A.
Nat. Cell Biol. 10:643-653(2008) [PubMed: 18488021] [Abstract]
Cited for: FUNCTION, INTERACTION WITH MYCN, MUTAGENESIS OF CYS-4341.
[24]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1368; SER-1395; SER-1907; SER-2362; SER-2365; SER-2887; SER-3662; SER-3919; THR-3924 AND THR-3927, MASS SPECTROMETRY.
[25]"Lysine acetylation targets protein complexes and co-regulates major cellular functions."
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M.
Science 325:834-840(2009) [PubMed: 19608861] [Abstract]
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-509; LYS-1840 AND LYS-2248, MASS SPECTROMETRY.
[26]"Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation."
Froyen G., Corbett M., Vandewalle J., Jarvela I., Lawrence O., Meldrum C., Bauters M., Govaerts K., Vandeleur L., Van Esch H., Chelly J., Sanlaville D., van Bokhoven H., Ropers H.-H., Laumonnier F., Ranieri E., Schwartz C.E., Abidi F. expand/collapse author list , Tarpey P.S., Futreal P.A., Whibley A., Raymond F.L., Stratton M.R., Fryns J.-P., Scott R., Peippo M., Sipponen M., Partington M., Mowat D., Field M., Hackett A., Marynen P., Turner G., Gecz J.
Am. J. Hum. Genet. 82:432-443(2008) [PubMed: 18252223] [Abstract]
Cited for: VARIANTS MRXS-TURNER HIS-2981; TRP-4013 AND CYS-4187, INVOLVEMENT IN MRX17.
+Additional computationally mapped references.

Cross-references

Sequence databases

AY772009 mRNA. Translation: AAV90838.1.
DQ097177 mRNA. Translation: AAY98258.1.
AY929612 mRNA. Translation: AAX24125.1.
AL592046, Z94044, Z97054 Genomic DNA. Translation: CAI39580.1.
Z94044, AL592046, Z97054 Genomic DNA. Translation: CAI42354.1.
Z97054, AL592046, Z94044 Genomic DNA. Translation: CAI42654.1.
AB071605 mRNA. Translation: BAC06833.1. Frameshift.
AB002310 mRNA. Translation: BAA20771.2.
AB046798 mRNA. Translation: BAB13404.1. Sequence problems.
AF161390 mRNA. Translation: AAF28950.1. Frameshift.
BC002602 mRNA. Translation: AAH02602.2.
BC063505 mRNA. Translation: AAH63505.1.
AF057569 mRNA. Translation: AAC62492.1. Different initiation.
CR456813 mRNA. Translation: CAG33094.1.
AL162050 mRNA. Translation: CAB82393.1.
IPIIPI00445401.
IPI00456919.
IPI00643153.
PIRT47165.
RefSeqNP_113584.3.
UniGeneHs.136905

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
2EKKNMR-A1317-1356[»]
3G1NX-ray2.60A/B4005-4374[»]
ModBaseSearch...

Protein-protein interaction databases

IntActQ7Z6Z7. 7 interactions.
STRINGQ7Z6Z7.

PTM databases

PhosphoSiteQ7Z6Z7.

Proteomic databases

PRIDEQ7Z6Z7.

Genome annotation databases

EnsemblENST00000218328; ENSP00000218328; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000262854; ENSP00000262854; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000276009; ENSP00000276009; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000342160; ENSP00000340648; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000375220; ENSP00000364368; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000396323; ENSP00000379615; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000424562; ENSP00000415122; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000426907; ENSP00000403236; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000427052; ENSP00000401253; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000432528; ENSP00000409234; ENSG00000086758; Homo sapiens. [Genome view]
ENST00000446750; ENSP00000413651; ENSG00000086758; Homo sapiens. [Genome view]
GeneID10075.
KEGGhsa:10075.
UCSCuc004dso.1. human.

Organism-specific databases

CTD10075.
GeneCardsGC0XM053575.
HGNCHGNC:30892. HUWE1.
HPACAB022718.
HPA002548.
MIM300697. gene.
300705. phenotype.
300706. phenotype.
PharmGKBPA128394567.
HUGESearch...
Search...
GenAtlasSearch...

Phylogenomic databases

HOVERGENQ7Z6Z7.

Gene expression databases

ArrayExpressQ7Z6Z7.
BgeeQ7Z6Z7.
GenevestigatorQ7Z6Z7.
GermOnlineENSG00000086758. Homo sapiens.

Family and domain databases

InterProIPR010309. E3_ubiquit_lig_DUF908.
IPR010314. E3_ubiquit_lig_DUF913.
IPR000569. HECT.
IPR000449. UBA/transl_elong_EF1B_N.
IPR015940. UBA/transl_elong_EF1B_N_euk.
IPR004170. WWE-dom.
[Graphical view]
PfamPF06012. DUF908. 1 hit.
PF06025. DUF913. 1 hit.
PF00632. HECT. 1 hit.
PF00627. UBA. 1 hit.
PF02825. WWE. 1 hit.
[Graphical view]
SMARTSM00119. HECTc. 1 hit.
SM00165. UBA. 1 hit.
[Graphical view]
PROSITEPS50237. HECT. 1 hit.
PS50030. UBA. 1 hit.
PS50330. UIM. False negative.
PS50918. WWE. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio38085.
SOURCESearch...

Entry information

Entry nameHUWE1_HUMAN
AccessionPrimary (citable) accession number: Q7Z6Z7
Secondary accession number(s): O15029 expand/collapse secondary AC list , Q4G2Z2, Q5H961, Q6P4D0, Q8NG67, Q9BUI0, Q9HCJ4, Q9NSL6, Q9P0A9
Entry history
Integrated into UniProtKB/Swiss-Prot: July 19, 2004
Last sequence update: August 30, 2005
Last modified: November 3, 2009
This is version 75 of the entry and version 3 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome X

Human chromosome X: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PATHWAY comments

Index of metabolic and biosynthesis pathways

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents